YEKEDÜZ, E. Et Al. 2021. The attrition of patients with metastatic renal cell carcinoma across treatment lines: A real-life experience from the Turkish oncology group kidney cancer consortium (TKCC) database. Kidney Cancer Research Summit 2021 , (United States Of America), 27.

YEKEDÜZ, E., KARAKAYA, S., TURAL, D., EROL, C., ERTÜRK, İ., ARSLAN, Ç., ... YAZGAN, S. C.(2021). The attrition of patients with metastatic renal cell carcinoma across treatment lines: A real-life experience from the Turkish oncology group kidney cancer consortium (TKCC) database . Kidney Cancer Research Summit 2021 (pp.27). , United States Of America

YEKEDÜZ, EMRE Et Al. "The attrition of patients with metastatic renal cell carcinoma across treatment lines: A real-life experience from the Turkish oncology group kidney cancer consortium (TKCC) database," Kidney Cancer Research Summit 2021, United States Of America, 2021

YEKEDÜZ, EMRE Et Al. "The attrition of patients with metastatic renal cell carcinoma across treatment lines: A real-life experience from the Turkish oncology group kidney cancer consortium (TKCC) database." Kidney Cancer Research Summit 2021 , United States Of America, pp.27, 2021

YEKEDÜZ, E. Et Al. (2021) . "The attrition of patients with metastatic renal cell carcinoma across treatment lines: A real-life experience from the Turkish oncology group kidney cancer consortium (TKCC) database." Kidney Cancer Research Summit 2021 , United States Of America, p.27.

@conferencepaper{conferencepaper, author={EMRE YEKEDÜZ Et Al. }, title={The attrition of patients with metastatic renal cell carcinoma across treatment lines: A real-life experience from the Turkish oncology group kidney cancer consortium (TKCC) database}, congress name={Kidney Cancer Research Summit 2021}, city={}, country={United States Of America}, year={2021}, pages={27} }